Metagenomi Inc. MGX) on Tuesday reported a loss of $19.9 million in its second quarter.

In May 2025, the Company reported additional long-term data from its nonhuman primate (“NHP”) study that demonstrated durable and consistent FVIII activity levels through approximately 19 months. Mean ...

Metagenomi (MGX) came out with a quarterly loss of $0.54 per share versus the Zacks Consensus Estimate of a loss of $0.68. This compares to a loss of $0.29 per share a year ago. These figures are ...

(Nasdaq: MGX) (the “Company”), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today announced the ...

Metagenomi, Inc. ( ($MGX) ) has shared an announcement. Metagenomi, Inc. reported its second quarter 2025 financial results and business updates, ...

SoftBank Group Corp. said it’s taking longer than anticipated to get Stargate off the ground, conceding for the first time ...

Venture capital investment in crypto & blockchain startups dropped by 59% in Q2 of 2025, with $1.976B raised across 378 deals ...

Senator Elizabeth Warren warns current crypto framework could 'blow up' US economy while blasting GENIUS ACT and Trump's ...

Tech companies are racing to build powerful data centers across the nation, especially as President Trump calls for increased ...

Donald Trump–backed DeFi project World Liberty Financial (WLFI) aims to establish a $1.5 billion crypto treasury firm.

Get the latest Metagenomi, Inc. (MGX) stock news and headlines to help you in your trading and investing decisions.

SoftBank's ambitious $500 billion "Stargate" AI project with OpenAI is facing delays as securing consensus among partners ...